oncogenic HPV

oncogenic HPV

A human papillomavirus–HPV genotype, especially types 16, 18, but also types 31, 33, and 51, which is pathogenically linked to intraepithelial neoplasia–eg, uterine cervix, termed CIN. See CIN, HPV.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women.
Human Papillomavirus Vaccine & Cancer Prevention: What you can do to protect your patients!
Cross-protective efficacy of HPV-16/18 AS04adjuvanted vaccine against cervical infection and pre-cancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda. (ISSUES IN PUBLIC HEALTH)
In 2014 Gardasil 9 was approved to extend coverage to an additional 5 oncogenic HPV types (31, 33, 45, 52, and 58), now covering an additional 20% of cervical cancers, and in 2015 Gardasil 9 indications were expanded to include boys and men 9 to 26 years of age.
The HPV vaccine is now recommended for adults aged 27-45: Counseling implications: Can we improve human papillomavirus (HPV) vaccination rates among boys and girls so "catch-up" vaccinations in adults are unnecessary?
2, 2018 (HealthDay News) -- Continuing regular cytology screening up to age 75 years or performing an exit human papillomavirus (HPV) test to confirm the absence of oncogenic HPV strains past the age of 55 years offers preventive benefit for older women with a cervix, according to a study published online Nov.
Age to Stop Cervical Cancer Screening Depends on Test Used; Negative HPV test, HPV-cytology co-test tied to low remaining lifetime cancer risk for unvaccinated
They observed elevated levels of the two biomarkers, which have been associated with a faster clearance of oncogenic HPV types [97].
New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress
Efficacy of human papillomavirus (HPV) - 16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types ( PATRICIA ): final analysis of a doubleblind, randomised study in young women.
The Need for Societal Investment to Improve Cervical Cancer Outcomes in Nigeria: A commentary
In addition, oestrogen acts as an anti-apoptotic agent permitting proliferation of cells infected with oncogenic HPV. It has been reported that steroid hormones found in oral contraceptives may affect the HPV genome and increase viral expression of oncoproteins E6 and E7.
PREVALENCE OF HUMAN PAPILLOMA VIRUS AND ITS ASSOCIATED RISK FACTORS IN WOMEN WITH ABNORMAL CYTOLOGY AT A TERTIARY CARE HOSPITAL OF NORTH INDIA
In the past two decades, Human Papilloma Virus (HPV) strains have been identified as a causative agent in cervical cancer in particular with high grade oncogenic HPV genotypes, such as HPV-16 and HPV-18, along with some other factors predispose women to cancer10,11.
AWARENESS AND KNOWLEDGE REGARDING RISK FACTORS AND COMMON SYMPTOMS OF CERVICAL CANCER AMONG FEMALE STUDENTS OF RAWALPINDI
The PCR method used in this study shows that oncogenic HPV DNA E6 and E7 from HPV-18 are in a significant proportion of the NPC cases studied.
Detection of Human Papillomavirus Genotypes and Epstein-Barr Virus in Nasopharyngeal Carcinomas at the Korle-Bu Teaching Hospital, Ghana
The 9-valent vaccine would prevent a broader range of oncogenic HPV types.
Anal cancer in HIV-infected patients: To screen or not?
Local data from Africa on the relationship between oncogenic HPV types, immune status and cervical preinvasive lesions are also incomplete.
Oncogenic and incidental HPV types associated with histologically confirmed cervical intraepithelial neoplasia in HIV-positive and HIV-negative South African women
Urban and rural populations live in different socioeconomic environments, lifestyles and life standards, which might explain the higher prevalence of overall HPV, oncogenic HPV and multiple-genotype HPV infections in urban populations.
Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, China

Medical browser ?
Full browser ?